SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+13.25%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$731M
AUM Growth
+$731M
(+5.8%)
Cap. Flow
+$30.8M
Cap. Flow
% of AUM
4.21%
Top 10 Holdings %
Top 10 Hldgs %
42.41%
Holding
130
New
31
Increased
26
Reduced
26
Closed
31
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$37M |
| 2 |
Novo Nordisk
NVO
|
$20.9M |
| 3 |
Bristol-Myers Squibb
BMY
|
$11.9M |
| 4 |
UroGen Pharma
URGN
|
$11.4M |
| 5 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$11.2M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$20.3M |
| 2 |
Viatris
VTRS
|
$19.1M |
| 3 |
Ituran Location and Control
ITRN
|
$14.6M |
| 4 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$11.9M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$10.2M |
Sector Composition
| 1 | Healthcare | 82.83% |
| 2 | Technology | 9.84% |
| 3 | Consumer Discretionary | 1.78% |
| 4 | Industrials | 1.62% |
| 5 | Communication Services | 0.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Caesarstone
CSTE
$49.1M
| $7.46M | 0.68% | 478,114 +8,954 | +2% | +$140K |
|
27
Microsoft
MSFT
$3.77T
| $7.24M | 0.66% | 61,397 +14,399 | +31% | +$1.7M |
|
|
AERI
28
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $7.13M | 0.65% | +150,000 | New | +$7.13M |
|
29
Biogen
BIIB
$19.4B
| $7.09M | 0.65% | +30,000 | New | +$7.09M |
|
|
RETA
30
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $6.99M | 0.64% | 81,769 -139,500 | -63% | -$11.9M |
|
|
ARQL
31
DELISTED
Arqule Inc
ARQL
| $6.86M | 0.63% | 1,432,643 -600,000 | -30% | -$2.87M |
|
|
SIOX
32
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $6.79M | 0.62% | 5,108,333 -3,091,667 | -38% | -$4.11M |
|
|
IMMU
33
DELISTED
Immunomedics Inc
IMMU
| $6.28M | 0.57% | 326,660 -379,879 | -54% | -$7.3M |
|
34
Camtek
CAMT
$3.78B
| $6.25M | 0.57% | +700,574 | New | +$6.25M |
|
|
AUTL
35
Autolus Therapeutics
AUTL
$399M
| $6.07M | 0.55% | 192,994 -10,000 | -5% | -$315K |
|
36
Krystal Biotech
KRYS
$4.27B
| $5.98M | 0.55% | 181,625 +7,000 | +4% | +$230K |
|
|
TVRD
37
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
| $5.96M | 0.54% | 303,930 | – | – |
|
38
Alphabet (Google) Class A
GOOGL
$2.57T
| $5.88M | 0.54% | +5,000 | New | +$5.88M |
|
|
MYOK
39
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $5.88M | 0.54% | +113,000 | New | +$5.88M |
|
|
MLNX
40
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $5.85M | 0.53% | 49,394 +21,043 | +74% | +$2.49M |
|
|
NEOS
41
DELISTED
Neos Therapeutics, Inc
NEOS
| $5.75M | 0.52% | 2,201,697 | – | – |
|
42
Xenon Pharmaceuticals
XENE
$2.98B
| $5.42M | 0.49% | 533,655 +84,171 | +19% | +$855K |
|
43
Amazon
AMZN
$2.44T
| $5.34M | 0.49% | +3,000 | New | +$5.34M |
|
44
AnaptysBio
ANAB
$569M
| $5.11M | 0.47% | +70,000 | New | +$5.11M |
|
45
Rocket Pharmaceuticals
RCKT
$354M
| $5.09M | 0.46% | 290,001 | – | – |
|
46
Minerva Neurosciences
NERV
$16.5M
| $5.05M | 0.46% | 642,018 -140,000 | -18% | -$1.1M |
|
47
Sutro Biopharma
STRO
$72.7M
| $4.99M | 0.46% | 437,889 +30,000 | +7% | +$342K |
|
|
SBBP
48
DELISTED
Strongbridge Biopharma plc.
SBBP
| $4.74M | 0.43% | 951,600 +20,000 | +2% | +$99.6K |
|
49
Mohawk Industries
MHK
$8.24B
| $4.67M | 0.43% | 37,000 +26,339 | +247% | +$3.32M |
|
50
uniQure
QURE
$896M
| $4.61M | 0.42% | 77,349 -155,500 | -67% | -$9.28M |
|